First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study (Q95562202)
Jump to navigation
Jump to search
No description defined
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study |
No description defined |
Statements
First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study (English)
Magdolna Dank
Laszlo Budi
Bela Piko
Laszlo Mangel
Jozsef Erfan
Jozsef Cseh
Agnes Ruzsa